Orographic Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Orographic Financial Advisors's BMY Position: Q2 2026 in Review
Orographic Financial Advisors reduced its Bristol-Myers Squibb (BMY) stake by 0.44% in Q2 2026, selling an estimated $12.9K and leaving 51,149 shares worth $3.26M. The position accounts for 2.16% of the portfolio, ranked #11.
Orographic Financial Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Orographic Financial Advisors held 51,149 shares of Bristol-Myers Squibb worth $3.26M as of Q2 2026.
- Orographic Financial Advisors sold 225 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.9K.
- Bristol-Myers Squibb made up 2.16% of Orographic Financial Advisors's portfolio in Q2 2026, its #11 holding.
- Orographic Financial Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Orographic Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.